Terms: = Breast cancer AND PREX2, 6230420N16Rik, DEPDC2, 80243, ENSG00000046889, FLJ12987, DEP_2, P-REX2
11 results:
1. Identification of new subtypes and potential genetic signatures in triple-negative breast cancer using weighted gene co-expression network analysis.
Huang J; Liao LY; Jiang WJ; Li YH; Lu BM; Wen ZP; Li FJ; Fang DL; Lu GM
Eur Rev Med Pharmacol Sci; 2024 Jan; 28(2):603-614. PubMed ID: 38305604
[TBL] [Abstract] [Full Text] [Related]
2. Genomic alteration profile and PD-L1 expression among different breast cancer subtypes in Chinese population and their correlations.
Li K; Cao L; Li C; Wu J; Chen B; Zhang G; Li X; Wen L; Jia M; Wei G; Lin J; Li Y; Zhang Y; Mok H; Ren C; Wang Y; Qi X; Guo L; Che Y; Liao N
Cancer Med; 2023 Mar; 12(5):5195-5208. PubMed ID: 36404592
[TBL] [Abstract] [Full Text] [Related]
3. Somatic Mutational Profile of High-Grade Serous Ovarian Carcinoma and Triple-Negative breast Carcinoma in Young and Elderly Patients: Similarities and Divergences.
Serio PAMP; de Lima Pereira GF; Katayama MLH; Roela RA; Maistro S; Folgueira MAAK
Cells; 2021 Dec; 10(12):. PubMed ID: 34944094
[TBL] [Abstract] [Full Text] [Related]
4. CELF2 suppresses non-small cell lung carcinoma growth by inhibiting the prex2-PTEN interaction.
Yeung YT; Fan S; Lu B; Yin S; Yang S; Nie W; Wang M; Zhou L; Li T; Li X; Bode AM; Dong Z
Carcinogenesis; 2020 May; 41(3):377-389. PubMed ID: 31241130
[TBL] [Abstract] [Full Text] [Related]
5. Perturbations of BMP/TGF-β and VEGF/VEGFR signalling pathways in non-syndromic sporadic brain arteriovenous malformations (BAVM).
Wang K; Zhao S; Liu B; Zhang Q; Li Y; Liu J; Shen Y; Ding X; Lin J; Wu Y; Yan Z; Chen J; Li X; Song X; Niu Y; Liu J; Chen W; Ming Y; Du R; Chen C; Long B; Zhang Y; Tong X; Zhang S; Posey JE; Zhang B; Wu Z; Wythe JD; Liu P; Lupski JR; Yang X; Wu N
J Med Genet; 2018 Oct; 55(10):675-684. PubMed ID: 30120215
[TBL] [Abstract] [Full Text] [Related]
6. P-Rex1 and p-rex2 RacGEFs and cancer.
Srijakotre N; Man J; Ooms LM; Lucato CM; Ellisdon AM; Mitchell CA
Biochem Soc Trans; 2017 Aug; 45(4):963-77. PubMed ID: 28710285
[TBL] [Abstract] [Full Text] [Related]
7. The Phosphatidylinositol (3,4,5)-Trisphosphate-dependent Rac Exchanger 1·Ras-related C3 Botulinum Toxin Substrate 1 (P-Rex1·Rac1) Complex Reveals the Basis of Rac1 Activation in breast cancer Cells.
Lucato CM; Halls ML; Ooms LM; Liu HJ; Mitchell CA; Whisstock JC; Ellisdon AM
J Biol Chem; 2015 Aug; 290(34):20827-20840. PubMed ID: 26112412
[TBL] [Abstract] [Full Text] [Related]
8. PTEN inhibits prex2-catalyzed activation of RAC1 to restrain tumor cell invasion.
Mense SM; Barrows D; Hodakoski C; Steinbach N; Schoenfeld D; Su W; Hopkins BD; Su T; Fine B; Hibshoosh H; Parsons R
Sci Signal; 2015 Mar; 8(370):ra32. PubMed ID: 25829446
[TBL] [Abstract] [Full Text] [Related]
9. Profiling the tyrosine phosphoproteome of different mouse mammary tumour models reveals distinct, model-specific signalling networks and conserved oncogenic pathways.
Ali NA; Wu J; Hochgräfe F; Chan H; Nair R; Ye S; Zhang L; Lyons RJ; Pinese M; Lee HC; Armstrong N; Ormandy CJ; Clark SJ; Swarbrick A; Daly RJ
Breast Cancer Res; 2014 Sep; 16(5):437. PubMed ID: 25200860
[TBL] [Abstract] [Full Text] [Related]
10. Molecular pathways: P-Rex in cancer.
Pandiella A; Montero JC
Clin Cancer Res; 2013 Sep; 19(17):4564-9. PubMed ID: 23753921
[TBL] [Abstract] [Full Text] [Related]
11. Melanoma genome sequencing reveals frequent prex2 mutations.
Berger MF; Hodis E; Heffernan TP; Deribe YL; Lawrence MS; Protopopov A; Ivanova E; Watson IR; Nickerson E; Ghosh P; Zhang H; Zeid R; Ren X; Cibulskis K; Sivachenko AY; Wagle N; Sucker A; Sougnez C; Onofrio R; Ambrogio L; Auclair D; Fennell T; Carter SL; Drier Y; Stojanov P; Singer MA; Voet D; Jing R; Saksena G; Barretina J; Ramos AH; Pugh TJ; Stransky N; Parkin M; Winckler W; Mahan S; Ardlie K; Baldwin J; Wargo J; Schadendorf D; Meyerson M; Gabriel SB; Golub TR; Wagner SN; Lander ES; Getz G; Chin L; Garraway LA
Nature; 2012 May; 485(7399):502-6. PubMed ID: 22622578
[TBL] [Abstract] [Full Text] [Related]
